Literature DB >> 29430701

Predictive value of the new renal response criteria in AL amyloidosis treated with high dose melphalan and stem cell transplantation.

Andrea Havasi1,2, Gheorghe Doros1,3, Vaishali Sanchorawala2,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29430701      PMCID： PMC5893431          DOI： 10.1002/ajh.25066

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  7 in total

1.  Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal disease.

Authors:  L M Dember; V Sanchorawala; D C Seldin; D G Wright; M LaValley; J L Berk; R H Falk; M Skinner
Journal:  Ann Intern Med       Date:  2001-05-01       Impact factor: 25.391

2.  Validation of new renal staging system in AL amyloidosis treated with high dose melphalan and stem cell transplantation.

Authors:  Andrea Havasi; Lauren Stern; Stephen Lo; Fangui Sun; Vaishali Sanchorawala
Journal:  Am J Hematol       Date:  2016-07-14       Impact factor: 10.047

3.  Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients.

Authors:  Maria Teresa Cibeira; Vaishali Sanchorawala; David C Seldin; Karen Quillen; John L Berk; Laura M Dember; Adam Segal; Frederick Ruberg; Hans Meier-Ewert; Nancy T Andrea; J Mark Sloan; Kathleen T Finn; Gheorghe Doros; Joan Blade; Martha Skinner
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

Review 4.  Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

Authors:  Morie A Gertz; Ray Comenzo; Rodney H Falk; Jean Paul Fermand; Bouke P Hazenberg; Philip N Hawkins; Giampaolo Merlini; Philippe Moreau; Pierre Ronco; Vaishali Sanchorawala; Orhan Sezer; Alan Solomon; Giles Grateau
Journal:  Am J Hematol       Date:  2005-08       Impact factor: 10.047

5.  A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis.

Authors:  Giovanni Palladini; Ute Hegenbart; Paolo Milani; Christoph Kimmich; Andrea Foli; Anthony D Ho; Marta Vidus Rosin; Riccardo Albertini; Remigio Moratti; Giampaolo Merlini; Stefan Schönland
Journal:  Blood       Date:  2014-08-12       Impact factor: 22.113

6.  Outcome in renal Al amyloidosis after chemotherapy.

Authors:  Jennifer H Pinney; Helen J Lachmann; Loveleen Bansi; Ashutosh D Wechalekar; Janet A Gilbertson; Dorota Rowczenio; Prayman T Sattianayagam; Simon D J Gibbs; Emanuela Orlandi; Nancy L Wassef; Arthur R Bradwell; Philip N Hawkins; Julian D Gillmore
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

7.  Renal risk and response in amyloidosis.

Authors:  Angela Dispenzieri
Journal:  Blood       Date:  2014-10-09       Impact factor: 22.113
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.